Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
Nutritional Science in the Prevention & Management of COPD
January 29, 2019
Designing Drugs to Better Help Real Lives
January 29, 2019
The Lung Health Research & Medicine Revolution
January 29, 2019
Clean Air and Lung Health
January 29, 2019
ERS Vision: Take the Active Option for your Health
January 29, 2019
Push-ups for Aspergillosis Research
January 29, 2019
What is Aspergillosis? – Fungal Infections & Symptoms
January 29, 2019
Aspergillosis & antibody testing
January 29, 2019
Patients Meeting – Rome 2010
January 29, 2019
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video